TE_46
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | THE1D |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 13.53 |
| Counts of samples | TCGA_tumor:23; TCGA_normal:0; GTEx:1 |
| TSS | chr1(-):4669472 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_46.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):4634263,4634283,4634393,4634526,4637986,4638206,4669377,4669473 |
| teRNA_46.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):4634263,4634283,4634393,4634521,4637986,4638206,4669377,4669473 |
| teRNA_46.3 | - | Intergenic | Other | MIVSLLRPPQPCGTRSLPGSFLCSQHEVEDDLQPEEGAQRGLEGHGAGTGLVVGAGTEIHFPRFPPRQCGPLPESPHTPVSEVLTDLLQGHVGEG* | chr1(-):4634501,4634521,4637986,4638211,4669377,4669473 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
